{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:39:38Z","timestamp":1790663978237,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000874","name":"Brain and Behavior Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000874","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005326","name":"Yale University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005326","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.bbr.2020.112713","type":"journal-article","created":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T10:19:52Z","timestamp":1590315592000},"page":"112713","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Inhibition of striatal-enriched protein tyrosine phosphatase (STEP) activity reverses behavioral deficits in a rodent model of autism"],"prefix":"10.1016","volume":"391","author":[{"given":"Manavi","family":"Chatterjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Lombroso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep K.","family":"Kurup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2020.112713_bib0005","doi-asserted-by":"crossref","first-page":"e520","DOI":"10.1542\/peds.2013-0763","article-title":"Economic burden of childhood autism spectrum disorders","volume":"133","author":"Lavelle","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.bbr.2020.112713_bib0010","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ijdevneu.2015.04.003","article-title":"Autistic spectrum disorders: a review of clinical features, theories and diagnosis","volume":"43","author":"Fakhoury","year":"2015","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.bbr.2020.112713_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6706a1","article-title":"Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2014","volume":"67","author":"Baio","year":"2018","journal-title":"Surveill. Summ."},{"key":"10.1016\/j.bbr.2020.112713_bib0020","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.reprotox.2016.04.024","article-title":"Genetic and non-genetic animal models for autism spectrum disorders (ASD)","volume":"64","author":"Ergaz","year":"2016","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.bbr.2020.112713_bib0025","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.neuroscience.2010.06.069","article-title":"Behavioral and molecular changes in the mouse in response to prenatal exposure to the anti-epileptic drug valproic acid","volume":"170","author":"Roullet","year":"2010","journal-title":"Neuroscience."},{"key":"10.1016\/j.bbr.2020.112713_bib0030","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/jama.2013.2270","article-title":"Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism","volume":"309","author":"Christensen","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.bbr.2020.112713_bib0035","doi-asserted-by":"crossref","first-page":"285","DOI":"10.5607\/en.2015.24.4.285","article-title":"Exploring the validity of valproic acid animal model of autism","volume":"24","author":"Mabunga","year":"2015","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.bbr.2020.112713_bib0040","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ntt.2013.01.004","article-title":"In utero exposure to valproic acid and autism--a current review of clinical and animal studies","volume":"36","author":"Roullet","year":"2013","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.bbr.2020.112713_bib0045","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.npp.1300518","article-title":"Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism","volume":"30","author":"Schneider","year":"2005","journal-title":"Neuropsychopharmacology."},{"key":"10.1016\/j.bbr.2020.112713_bib0050","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1124\/pr.110.003053","article-title":"Therapeutic implications for striatal-enriched protein tyrosine phosphatase (STEP) in neuropsychiatric disorders","volume":"64","author":"Goebel-Goody","year":"2012","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbr.2020.112713_bib0055","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8136925","article-title":"Role of striatal-enriched tyrosine phosphatase in neuronal function","volume":"2016","author":"Kamceva","year":"2016","journal-title":"Neural Plast."},{"key":"10.1016\/j.bbr.2020.112713_bib0060","doi-asserted-by":"crossref","first-page":"24274","DOI":"10.1074\/jbc.M111683200","article-title":"Striatal enriched phosphatase 61 dephosphorylates Fyn at phosphotyrosine 420","volume":"277","author":"Nguyen","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbr.2020.112713_bib0065","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/syn.20608","article-title":"Knockout of striatal enriched protein tyrosine phosphatase in mice results in increased ERK1\/2 phosphorylation","volume":"63","author":"Venkitaramani","year":"2009","journal-title":"Synapse"},{"key":"10.1016\/j.bbr.2020.112713_bib0070","doi-asserted-by":"crossref","first-page":"20942","DOI":"10.1074\/jbc.M112.368654","article-title":"Striatal-enriched protein-tyrosine phosphatase (STEP) regulates Pyk2 kinase activity","volume":"287","author":"Xu","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbr.2020.112713_bib0075","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/jnc.13160","article-title":"Striatal-enriched protein tyrosine phosphatase regulates the PTPalpha\/Fyn signaling pathway","volume":"134","author":"Xu","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbr.2020.112713_bib0080","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/nn1503","article-title":"Regulation of NMDA receptor trafficking by amyloid-beta","volume":"8","author":"Snyder","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbr.2020.112713_bib0085","doi-asserted-by":"crossref","first-page":"10561","DOI":"10.1523\/JNEUROSCI.2666-08.2008","article-title":"The tyrosine phosphatase STEP mediates AMPA receptor endocytosis after metabotropic glutamate receptor stimulation","volume":"28","author":"Zhang","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2020.112713_bib0090","article-title":"STEP inhibition prevents A\u03b2-mediated damage in dendritic complexity and spine density in Alzheimer\u2019s disease","author":"Chatterjee","year":"2020","journal-title":"bioRxiv."},{"key":"10.1016\/j.bbr.2020.112713_bib0095","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1007\/s00018-013-1391-4","article-title":"SPIN90 dephosphorylation is required for cofilin-mediated actin depolymerization in NMDA-stimulated hippocampal neurons","volume":"70","author":"Cho","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbr.2020.112713_bib0100","doi-asserted-by":"crossref","first-page":"5948","DOI":"10.1523\/JNEUROSCI.0157-10.2010","article-title":"Abeta-mediated NMDA receptor endocytosis in Alzheimer\u2019s disease involves ubiquitination of the tyrosine phosphatase STEP61","volume":"30","author":"Kurup","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2020.112713_bib0105","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1038\/tp.2012.63","article-title":"The tyrosine phosphatase STEP: implications in schizophrenia and the molecular mechanism underlying antipsychotic medications","volume":"2","author":"Carty","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbr.2020.112713_bib0110","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1073\/pnas.1417423112","article-title":"STEP61 is a substrate of the E3 ligase parkin and is upregulated in Parkinson\u2019s disease","volume":"112","author":"Kurup","year":"2015","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.bbr.2020.112713_bib0115","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1601-183X.2012.00781.x","article-title":"Genetic manipulation of STEP reverses behavioral abnormalities in a fragile X syndrome mouse model","volume":"11","author":"Goebel-Goody","year":"2012","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.bbr.2020.112713_bib0120","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1007\/s12035-015-9335-7","article-title":"BDNF induces striatal-enriched protein tyrosine phosphatase 61 degradation through the proteasome","volume":"53","author":"Saavedra","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbr.2020.112713_bib0125","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/j.1601-183X.2010.00627.x","article-title":"Increased BDNF levels and NTRK2 gene association suggest a disruption of BDNF\/TrkB signaling in autism","volume":"9","author":"Correia","year":"2010","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.bbr.2020.112713_bib0130","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.pbb.2011.06.023","article-title":"Glutamate mediated signaling in the pathophysiology of autism spectrum disorders","volume":"100","author":"Choudhury","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbr.2020.112713_bib0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121605","article-title":"Dopamine and the development of executive dysfunction in autism spectrum disorders","volume":"10","author":"Kriete","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbr.2020.112713_bib0140","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.expneurol.2008.07.014","article-title":"Striatal-enriched protein tyrosine phosphatase regulates dopaminergic neuronal development via extracellular signal-regulated kinase signaling","volume":"214","author":"Kim","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbr.2020.112713_bib0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001923","article-title":"Inhibitor of the tyrosine phosphatase STEP reverses cognitive deficits in a mouse model of Alzheimer\u2019s disease","volume":"12","author":"Xu","year":"2014","journal-title":"PLoS Biol."},{"key":"10.1016\/j.bbr.2020.112713_bib0150","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0091-3057(80)90067-2","article-title":"Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines","volume":"13","author":"Crawley","year":"1980","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbr.2020.112713_bib0155","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/0278-5846(89)90047-X","article-title":"Neuropharmacological and physiological validation of a computer-controlled two-compartment black and white box for the assessment of anxiety","volume":"13","author":"Onaivi","year":"1989","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2020.112713_bib0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026077","article-title":"mGluR5-antagonist mediated reversal of elevated stereotyped, repetitive behaviors in the VPA model of autism","volume":"6","author":"Mehta","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbr.2020.112713_bib0165","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ijdevneu.2013.09.002","article-title":"Acute prenatal exposure to a moderate dose of valproic acid increases social behavior and alters gene expression in rats","volume":"31","author":"Cohen","year":"2013","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.bbr.2020.112713_bib0170","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12993-016-0087-y","article-title":"Neuronal mechanisms and circuits underlying repetitive behaviors in mouse models of autism spectrum disorder","volume":"12","author":"Kim","year":"2016","journal-title":"Behav. Brain Funct."},{"key":"10.1016\/j.bbr.2020.112713_bib0175","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1001\/jama.2011.1638","article-title":"Neuron number and size in prefrontal cortex of children with autism","volume":"306","author":"Courchesne","year":"2011","journal-title":"JAMA."},{"key":"10.1016\/j.bbr.2020.112713_bib0180","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40478-019-0684-8","article-title":"Postnatal development and maturation of layer 1 in the lateral prefrontal cortex and its disruption in autism","volume":"7","author":"Trutzer","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.bbr.2020.112713_bib0185","doi-asserted-by":"crossref","first-page":"39822","DOI":"10.1038\/srep39822","article-title":"Atypical developmental trajectory of local spontaneous brain activity in autism spectrum disorder","volume":"7","author":"Guo","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbr.2020.112713_bib0190","doi-asserted-by":"crossref","first-page":"9228","DOI":"10.1523\/JNEUROSCI.3340-04.2004","article-title":"Autism and abnormal development of brain connectivity","volume":"24","author":"Belmonte","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2020.112713_bib0195","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/jnc.12147","article-title":"Male-specific alteration in excitatory post-synaptic development and social interaction in pre-natal valproic acid exposure model of autism spectrum disorder","volume":"124","author":"Kim","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbr.2020.112713_bib0200","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nrn2851","article-title":"Behavioural phenotyping assays for mouse models of autism","volume":"11","author":"Silverman","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbr.2020.112713_bib0205","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/nn1765","article-title":"Fragile X syndrome and autism at the intersection of genetic and neural networks","volume":"9","author":"Belmonte","year":"2006","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbr.2020.112713_bib0210","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cell.2011.06.013","article-title":"FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism","volume":"146","author":"Darnell","year":"2011","journal-title":"Cell."},{"key":"10.1016\/j.bbr.2020.112713_bib0215","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neuropharm.2017.09.026","article-title":"STEP inhibition reverses behavioral, electrophysiologic, and synaptic abnormalities in Fmr1 KO mice","volume":"128","author":"Chatterjee","year":"2018","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.bbr.2020.112713_bib0220","doi-asserted-by":"crossref","DOI":"10.1002\/prca.201900068","article-title":"The\u2019 Omics\u2019 of epigenetic modulation by valproic acid treatment in traumatic brain injury-what we know and what the future holds","volume":"13","author":"Bhatti","year":"2019","journal-title":"Proteomics Clin. Appl."},{"key":"10.1016\/j.bbr.2020.112713_bib0225","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/jnc.13295","article-title":"Down-regulation of BDNF in cell and animal models increases striatal-enriched protein tyrosine phosphatase 61 (STEP61) levels","volume":"136","author":"Xu","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbr.2020.112713_bib0230","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.pnpbp.2006.06.018","article-title":"Reduced serum levels of brain-derived neurotrophic factor in adult male patients with autism","volume":"30","author":"Hashimoto","year":"2006","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2020.112713_bib0235","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1007\/s00018-015-2057-1","article-title":"Inhibition of the tyrosine phosphatase STEP61 restores BDNF expression and reverses motor and cognitive deficits in phencyclidine-treated mice","volume":"73","author":"Xu","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbr.2020.112713_bib0240","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00213-011-2594-8","article-title":"A new synthetic varacin analogue, 8-(trifluoromethyl)-1,2,3,4,5-benzopentathiepin-6-amine hydrochloride (TC-2153), decreased hereditary catalepsy and increased the BDNF gene expression in the hippocampus in mice","volume":"221","author":"Kulikov","year":"2012","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.bbr.2020.112713_bib0245","doi-asserted-by":"crossref","first-page":"10252","DOI":"10.1038\/srep10252","article-title":"Transient blockade of ERK phosphorylation in the critical period causes autistic phenotypes as an adult in mice","volume":"5","author":"Yufune","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbr.2020.112713_bib0250","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13229-018-0221-9","article-title":"Sociability deficits after prenatal exposure to valproic acid are rescued by early social enrichment","volume":"9","author":"Campolongo","year":"2018","journal-title":"Mol. Autism"},{"key":"10.1016\/j.bbr.2020.112713_bib0255","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/jnr.22580","article-title":"Requirement for the endocannabinoid system in social interaction impairment induced by coactivation of dopamine D1 and D2 receptors in the piriform cortex","volume":"89","author":"Zenko","year":"2011","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbr.2020.112713_bib0260","doi-asserted-by":"crossref","first-page":"9023","DOI":"10.1523\/JNEUROSCI.0918-12.2012","article-title":"Dual control of dopamine synthesis and release by presynaptic and postsynaptic dopamine D2 receptors","volume":"32","author":"Anzalone","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2020.112713_bib0265","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuroscience.2014.01.025","article-title":"The role of D2-autoreceptors in regulating dopamine neuron activity and transmission","volume":"282","author":"Ford","year":"2014","journal-title":"Neuroscience."},{"key":"10.1016\/j.bbr.2020.112713_bib0270","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.bbr.2016.09.003","article-title":"Downregulation of glutamatergic and GABAergic proteins in valproric acid associated social impairment during adolescence in mice","volume":"316","author":"Chau","year":"2017","journal-title":"Behav. Brain Res."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432820304125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432820304125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T13:20:56Z","timestamp":1759065656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432820304125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":54,"alternative-id":["S0166432820304125"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2020.112713","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.04.17.047597","asserted-by":"object"}]},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of striatal-enriched protein tyrosine phosphatase (STEP) activity reverses behavioral deficits in a rodent model of autism","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2020.112713","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112713"}}